A

ACON

ACON

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
61%Neutral
Buy/Sell Ratio100% buys
BearishBullish
ACON Live QuoteReal-time
$1.42
$0.53(-27.18%)1M
Day Range$1.35 – $1.46
Open$1.35
Previous Close$1.34
Volume19.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$4.06M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-5.01
Price to Book0.3
Dividend Yield0.65%
Beta (Volatility)1.21
IndustryHEALTH INFORMATION SERVICES
52-Week RangeCurrent: $1.42 (1%)
Low: $1.33High: $9.36
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$7.62-94.9% upside

Insider Buys

11

$177K

Insider Sales

0

$0

Total Volume

$177K

18 transactions

Net Activity

+$177K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 7 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys7 sells

$2.40B total

B
2

Bond Ryan

Dir

1 buys0 sells

$50K total

N
3

Ness Brent

CEO

3 buys0 sells

$32K total

N
4

Neal David K

Dir

2 buys0 sells

$26K total

G
5

Gould Gregory A

CFO

1 buys0 sells

$25K total

Trading History
ACON insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 17, 2026

3 months ago

Williams Amanda M

Dir

Director
Buy5.9K$2.73$16K

Aug 17, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell25.9K$5857.00$151.44M

Aug 14, 2026

3 months ago

Gould Gregory A

CFO

CFO
Buy10.0K$2.45$25K

Aug 14, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell60.0K$10000.00$600.00M

Aug 13, 2026

3 months ago

Bond Ryan

Dir

Director
Buy21.1K$2.37$50K

Aug 13, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell76.1K$21122.00$1.61B

Aug 13, 2026

3 months ago

Wesemann William

Dir

Director
Buy2.1K$2.34$5K

Aug 13, 2026

3 months ago

Neal David K

Dir

Director
Buy7.5K$2.40$18K

Aug 13, 2026

3 months ago

Ness Brent

CEO

CEO
Buy5.2K$2.31$12K

May 11, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.5K$2500.00$6.25M

May 12, 2026

6 months ago

Breidbart Scott

Dir

Director
Buy5.7K$3.18$18K

May 11, 2026

6 months ago

Neal David K

Dir

Director
Buy2.5K$3.10$8K

May 12, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell5.7K$5664.00$32.08M

May 11, 2026

6 months ago

Ness Brent

CEO

CEO
Buy6.3K$3.18$20K

May 6, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.6K$1562.00$2.44M

May 6, 2026

6 months ago

Wesemann William

Dir

Director
Buy1.6K$3.30$5K

Nov 26, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell11$10.00$110

Nov 26, 2025

11 months ago

Ness Brent

CEO

CEO
Buy10$6.20$62
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ACON Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

ACON has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ACON

Over the last 90 days, corporate insiders at ACON (ACON) engaged in a total of 18 transactions reported via SEC Form 4 filings. Among these, 11 were open-market purchases and 0 were sales. The total volume of insider trading reached $177K.

The net insider activity for ACON shows a net buying bias of $177K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 76.1K shares valued at $1.61B on Aug 13, 2026.

Live Market News & Developments
Aggregated real-time headlines for ACON (ACON)
6 updates

Aclarion (ACON) CFO Gould bought 3,388 shares for $4,879 at $1.44

Quantisnow7h ago

Aclarion CFO Gregory Gould buys $4,878 in company stock. By Investing.com

Investing.com Canada6h ago

ACON - Aclarion Inc Stock Price and Quote

Finviz178d ago

Aclarion (ACON) Upgraded to Buy: Here's Why

Yahoo Finance185d ago

Aclarion, Inc. Stock Price Today | ACON Live Chart & News

Traders Union21d ago

Aclarion CFO Gregory Gould buys $4,878 in company stock. By Investing.com

Investing.com India6h ago

FAQs About ACON Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ACON.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ACON is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 11 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for ACON is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.